1. 515PPolypharmacy as a prognostic factor in elderly patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors. (24th November 2019) Authors: Hakozaki, T; Kitadai, R; Hosomi, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 518POutcomes of EGFR-TKIs for patients with non-small cell lung cancer harboring EGFR mutations with poor performance status. (25th November 2018) Authors: Hashimoto, K; Okuma, Y; Hakozaki, T; Watanabe, K; Hosomi, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗